Quick Answer
NovaBridge Biosciences reported Total Revenue of $632.0 thousand for fiscal year 2023.
NovaBridge Biosciences Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2023 | $632.0K | +140.7% |
| 2022 | -$1.55M | -101.8% |
| 2021 | $88.03M | -94.3% |
| 2020 | $1.54B | +5042.2% |
| 2019 | $30.00M | -44.2% |
| 2018 | $53.78M | +365.4% |
| 2017 | $11.56M | — |
- NovaBridge Biosciences showed an increase of +140.7% in Total Revenue compared to the prior fiscal year.
- Over the 2017–2023 period, NovaBridge Biosciences’s total revenue has declined by 94.5% (from $11.56 million to $632.0 thousand).
- The most recent figure is from NovaBridge Biosciences’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: